OFFICIAL-SOURCE RECALL · UNITED KINGDOM
MHRA Safety Roundup: July 2026 Recall: of iatrogenic botulism Summary Key Advice for
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- MHRA Safety Roundup: July 2026
- Manufacturer
- See official notice
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
of iatrogenic botulism Summary Key Advice for Healthcare Professionals Key Advice for Healthcare Professionals to Provide to Patients Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension Summary Key Advice for Healthcare Professionals Key Advice for Healthcare Professionals to Provide to Patients Letters, medicines recalls and device notifications sent to healthcare professionals in July 2026 Direct Healthcare Professional Communications Medicine Recalls and Notifications Medical Device Field Safety Notices Report suspected drug reactions and device incidents on a Yellow Card Report a medicine Reporting for medical devices Reporting for patients News Roundup Immune checkpoint inhibitors: product information updated to include myocarditis-myositis-myasthenia gravis overlap syndrome Bladder anticholinergics: review of risk of dementia To subscribe to monthly email alerts of MHRA Safety Roundup visit our sign up page Download Document MHRA Safety Roundup: July 2026 Please access the PDF version of our Safety Roundup for our easy-read template and QR codes to access the full articles. Botulinum toxin type A products: updated warnin
Hazard
of iatrogenic botulism Summary Key Advice for Healthcare Professionals Key Advice for Healthcare Professionals to Provide to Patients Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension Summary Key Advice for Healthcare Professionals Key Advice for Healthcare Professionals to Provide to Patients Letters, medicines recalls and device notifications sent to healthcare professionals in July 2026 Direct Healthcare Professional Communications Medicine Recalls and Notifications Medical Device Field Safety Notices Report suspected drug reactions and device incidents on a Yellow Card Report a medicine Reporting for medical devices Reporting for patients News Roundup Immune checkpoint inhibitors: product information updated to include myocarditis-myositis-myasthenia gravis overlap syndrome Bladder anticholinergics: review of risk of dementia To subscribe to monthly email alerts of MHRA Safety Roundup visit our sign up page Download Document MHRA Safety Roundup: July 2026 Please access the PDF version of our Safety Roundup for our easy-read template and QR codes to access the full articles. Botulinum toxin type A products: updated warnin
Official recall notice
MHRA Safety Roundup: July 2026
Agency: Medicines and Healthcare products Regulatory Agency
Official publication date: July 30, 2026
Read the official UK_MHRA recall notice →Scan products you own
Scan products you own once and let RecallGuard monitor future official recalls.
Scan & Monitor Products